Published in Gastroenterology Week, July 13th, 2009
"New mucosal ablative techniques have emerged to treat Barrett's esophagus with high-grade dysplasia in an effort to prevent the progression to esophageal adenocarcinoma. Esophageal cancer is the 7th most prevalent cancer in the world and has a very poor 5-year survival rate," wrote L....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.